NDC Product
Drug For Further Processing- Generic Name
- Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate
- Dosage Form
- Tablet, Film Coated
- Route
- N/A
- Marketing
- DRUG FOR FURTHER PROCESSING
Active Listing
Efavirenz 600 mg / emtricitabine 200 mg / tenofovir disoproxil fumarate 300 mg Oral Tablet
RxNorm 643066 NDC Crossover
NDC Directory Crossover & Product Mapping
The following National Drug Codes (NDCs) are directly associated with the clinical concept for Efavirenz 600 mg / emtricitabine 200 mg / tenofovir disoproxil fumarate 300 mg Oral Tablet (RxCUI 643066). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.
Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.
